Goldman Sachs analyst Mark Delaney downgraded Mobileye shares to Hold from Buy. He left his price target unchanged, however, ...

The ‘Trump accounts’ plan echoes a years-old proposal for ‘baby bonds’ introduced by New Jersey Sen. Cory Booker ...

As worries over trade tensions subside, investors are shifting focus to the effect of persistently high interest rates, a ...

Goldman Sachs analysts led by Steven Kron share the firm's latest conviction list, which includes 23 of the bank's top picks ...

Inc to Neutral from Buy given a weaker-than-expected market share gains, rising competition in advanced driver assistance systems (ADAS) and autonomous vehicles (AV), and a valuation that appears full ...

Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 8:00 AM ETCompany ParticipantsAlbert Bourla - Chairman of ...

The housing market remains constrained in 2025. Goldman said mortgage rates will stay elevated, raising its year-end target ...

Motilal Oswal bought the biggest chunk of Suzlon Energy shares as part of Monday's block deal, followed by Aditya Birla Sun ...

Goldman Sachs has added these three stocks to its Conviction List. They all have at least 20% upside potential to the analyst ...

Goldman Sachs has moderated its risk-taking since U.S. President Donald Trump's April tariff announcement, and the Wall ...

Hedge funds bought global equities last week at the quickest pace since November 2024, Goldman Sachs said in a note, just as ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) 46th Annual Goldman Sachs Global Healthcare Conference June 9, 2025 10:40 AM ETCompany ...